Opinion|Videos|July 8, 2024
Multidisciplinary Strategies for Treating RCC
Author(s)Martin H. Voss, MD
A genitourinary oncologist discusses the role of multidisciplinary care in the treatment of patients with advanced renal cell carcinoma.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- Please share your institutional perspective on the multidisciplinary team approach to treatment selection and care for advanced renal cell carcinoma (RCC)?
Advertisement
Related to this article
LITESPARK-012 data at ESMO 2026 show that adding belzutifan or quavonlimab to pembrolizumab/lenvatinib did not improve survival for advanced kidney cancer.
Advertisement
Advertisement
Trending on Targeted Onc
1
A New Era in Sarcoma Treatment? Dr Banks on the Potential of TIL Therapy
2
FDA Approves Generic Venetoclax Tablets for CLL/SLL and AML
3
Enzalutamide Fails to Improve Survival in High-Risk Prostate Cancer
4
Neoadjuvant Botensilimab/Balstilimab Shows Activity in Colon Cancer
5